Home

Our Objectives
EMA Activities

EMA’s objectives all focus on the same object: improvement of the medical profession in the European context.

  • To act in order to influence Health policies according to practising doctors’ priorities
  • To form a forum of doctors working in the European Union’s medical community
  • To provide its members with information and services that facilitate their professional activity
  • To contribute to the improvement of healthcare given to patients by helping its members keep abreast of latest the developments
  • To influence the development of health care in Europe by defending its members’ opinions

These objectives are ambitious, yet realistic.

EMA has been active on many different projects in the scope of its activities, you are invited to discover them in the “Projects” section of this web site. EMA also offers a range of “Information & Services” aimed at health professionals that are also available on this web site. Use the navigation menu to explore them.

Proof of your qualifications

To work as a doctor in another EU country, you must apply to the authority that oversees the doctor profession in that country, providing proof of your qualifications. The authority must:

  • acknowledge your application within 1 month of receiving it, and ask you missing but necessary documents to process the application
  • assess your qualifications and decide whether to grant your application within 3 months (or 4 months for certain complicated cases in the area of non automatic recognition)

Rose of Paracelsus

The medal of Paracelsus and the Rose of Paracelsus, are two awards established by EMA in cooperation with EBA

The Paracelsus medal is intended to reward physicians with at least 25 years of professional activity, and who meet the meet the following criteria

  • To be Medical Doctor
  • At least 25 years of professional activity,
  • Recent clean criminal record

The Rose of Paracelsus is an award that is given to those  who have excelled in the field of public health, in the organization, implementation and modernization of care and health services in general.

Everyone who has been given this recognition, will be incorporated in an official register kept in the archives of EMA  and published on our sites.

If you are interrested, please register as full membership.

For full active members, please click here under to proceed to the solicitation form

The EU Framework Programme for Research and Innovation

Horizon 2020 is the biggest EU Research and Innovation programme ever with nearly €80 billion of funding available over 7 years (2014 to 2020) -in addition to the private investment that this money will attract. It promises more breakthroughs, discoveries and world-firsts by taking great ideas from the lab to the market.

Horizon 2020 is the financial instrument implementing the Innovation Union, a Europe 2020 flagship initiative aimed at securing Europe’s global competitiveness. Seen as a means to drive economic growth and create jobs, Horizon 2020 has the political backing of Europe s leaders and the Members of the European Parliament. They agreed that research is an investment in our future and so put it at the heart of the EU s blueprint for smart, sustainable and inclusive growth and jobs.

By coupling research and innovation, Horizon 2020 is helping to achieve this with its emphasis on excellent science, industrial leadership and tackling societal challenges. The goal is to ensure Europe produces world-class science, removes barriers to innovation and makes it easier for the public and private sectors to work together in delivering innovation. Horizon 2020 is open to everyone, with a simple structure that reduces red tape and time so participants can focus on what is really important. This approach makes sure new projects get off the ground quickly -and achieve results faster.

The EU Framework Programme for Research and Innovation will be complemented by further measures to complete and further develop the European Research Area. These measures will aim at breaking down barriers to create a genuine single market for knowledge, research and innovation.

HEALTH GUIDELINES

WHO guidelines approved by the Guidelines Review Committee

The development of global guidelines ensuring the appropriate use of evidence represents one of the core functions of WHO. Recommendations that can impact upon health policies or clinical interventions are considered guidelines for WHO purposes. Below are some of the most recent guidelines.

NICE – National Institute for Health and Care Excellence

Lists of NICE guidance, including published guidance, in development and consultations

AHRQ – Agency for Healthcare Research and Quality

NGC – National Guidelines Clearinghouse is a public resource for evidence-based clinical practice guidelines.

Rehab 4 Alcoholism

Rehab 4 Alcoholism is a free and impartial helpline for people troubled with drug and alcohol issues. This aims to save lives by stopping addiction before it becomes too late. Tel: 0800 111 4108

EMA – European Medicines Agency Scientific Guidelines

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) prepares scientific guidelines in consultation with regulatory authorities in the European Union (EU) Member States, to help applicants prepare marketing-authorisation applications for human medicines. Guidelines provide a basis for practical harmonisation of how the EU Member States and the Agency interpret and apply the detailed requirements for the demonstration of quality, safety and efficacy that are in the Community directives.

DS MediGroup

The protagonists of innovation in Medicine and Health Share holding company, checks and attends companies in the area of IT Health Care.  Coordinates the activity and supporting the operational companies in different areas  as R & D, infrastructure, logistics and administrative, internal continuous educational process, new communication tools setup and deployment for the targeting activities  and the community. The national and international research institutes and university  clinics collaboration enables searches and developments of the technological innovation  in the sanitary management and clinical medicine applications. The head office is located in Milano with branches in Rome and Naples.

Medical Devices and Safety

The role of medical devices is essential to the healthcare of EU citizens. The diversity and innovativeness of this sector contributes significantly to the enhancement of both the quality and efficacy of healthcare in the EU. Covering a wide range of products, from simple bandages to the most sophisticated life-support equipment, the medical devices sector plays a crucial role in the diagnosis, prevention, monitoring and treatment of diseases. It also helps improve the quality of life of those with disabilities. The medical devices sector helps save lives by providing innovative health care solutions regarding diagnosis, prevention and treatment. The sector has become increasingly important for the healthcare of EU citizens and an influencer on expenditure:

  • The medical devices industry is a major employer in Europe, employing 575.000 people in the EU
  • Total sales amount to €100 billion
  • The sector represents some 25.000 companies, of which 95% are Small and Medium-sized Enterprises (SMEs)

The medical devices sector faces many challenges at national, European and international level, which may have an impact on their innovation capacity and overall competitiveness:

Public Health Systems: In particular, emerging needs such as developing a shared understanding of healthcare goals, overcoming health inequalities, an ageing society and exploiting the potential of e-health technologies

Finding the balance between patient s needs and financial sustainability: Ensuring that the sector can enhance better access for patients to devices whilst simultaneously ensuring that pricing and reimbursement policies are effective

Competitiveness and innovation: Challenges related to R&D, emerging technologies and the green economy, as well as issues related to the EU s trade and regulatory cooperation globally. SMEs in particular face challenges in this regard

President

Prof Vincenzo Costigliola

Prof Vincenzo Costigliola

President
Belgium

Dr. Costigliola graduated in Medicine from the University of Naples in 1972 and with distinction, in Anesthesiology and Intensive Care from the University of Pisa in 1978. He also completed studies in Rheumatology, Dermatology, Procthology, Oncology, Surgery, Drugs Abuse, Emergency Treatment, Disaster Action, Hospital Organization, Medical Teaching Methodology and Computer and Audio-Visual Training for the Medical Profession.

He holds prominent positions in multiple prestigious organizations, including being the President of EPMA (European Predictive, Preventive, Personalized Medicine), the President of E.D.A. (European Depression Association), and the President of Medicinal Cannabis Europe since 2020. They serve on the Board of “The European Biotechnology Association” and are a Fellow of the World Certification Institute, where they also serve as a Councilor. Additionally, they are the President of the Oxford Union Academic Board of Directors and a member of the International Advisory Board at King Abdulaziz University in Saudi Arabia. He also a board member of CIRM in Rome (Centro Internazionale Radio Medico) and Councilor of WCI

His editorial experience includes serving on the board of the EPMA Journal (BMC/Springer), and With significant experience in clinical trials, European healthcare, and participation in EU projects (DG 22 and DG 5),  he selected as an expert evaluator in the 5th Framework Programme. He possess extensive expertise in health informatics programs, teaching, and speaking at national and international conferences. He is proficient in Italian, French, English, Spanish, and Portuguese, and  have been recognized with numerous honors, including being named Cavaliere Ufficiale and Commendatore of the Italian Republic, receiving the Diploma di benemerenza with “medaglia di la classe” from the Italian Red Cross, and being honored as Equitem Commendatorem Ordinis Sancti Gregorii Magni.

Board Members

Prof Manuel Pais Clemente

Prof Manuel Pais Clemente

Vice president
A renowned medical professional from Porto, Portugal, has significantly advanced medicine and public health. A graduate of Porto University School of Medicine, he has held prominent roles, including Chairman of Otorhinolaryngology at Porto University and President of the World Voice Consortium. As a founding member of SCOHRE, he remains a global leader in smoking control and harm reduction policies.
Dr Angelo Manenti

Dr Angelo Manenti

Secretary General
A distinguished specialist in Occupational Medicine and Legal & Insurance Medicine, serves as the Secretary General of the European Medical Association (EMA). With extensive expertise in workplace health and legal medical practices, he plays a pivotal role in advancing healthcare standards and fostering international collaboration within the medical community.
Dr Prisco Piscitelli

Dr Prisco Piscitelli

Managing Director
Vice President of the Italian Society of Environmental Medicine (SIMA), is an esteemed epidemiologist and board member of the UNESCO Chair on Health Education and Sustainable Development at the University Federico II in Naples. With a medical degree, specialization in Public Health, and a PhD in Biology and Biotechnology, he is an adjunct professor at the University of Salento and a specialist at Vito Fazzi Hospital, Lecce.
Prof Francesco Amenta

Prof Francesco Amenta

Treasurer
A renowned neurologist with over 400 international publications and serving as president of the International Radio Medical Centre (CIRM). He leads advanced training programs in telemedicine, including a Master’s in eHealth and an International Master in Oil and Gas Telemedicine and Telepharmacy. With decades of experience at CIRM, he has served as Scientific Director since 2004.
Prof Guglielmo Trovato

Prof Guglielmo Trovato

Media Director
Expert in health, education, and communication along with media Relations Manager for the European Depression Association. A former Professor of Human Sciences in Medicine and Health Anthropology at the University of Catania, he brings two decades of academic experience. He excels in bridging healthcare, education, and scientific outreach.
Prof Paolo Baron

Prof Paolo Baron

Training Courses Coordinator
Surgeon and psychotherapist registered with the Medical Association of Udine specializing in acupuncture, homeopathy, phytotherapy, and hypnotherapy with ESH and SIPMU certifications. General Practitioner with Ass. n. 2 “Bassa Friulana” since 1982, operating a fully computerized office with a nurse and assistant. He holds a Master's in Health Management from MIB Trieste
Prof Luigi Gatta

Prof Luigi Gatta

Sport and Regenerative Medicine referent
National Coordinator for Sports Medicine at SIMG and Health Coordinator for the Winter Sports Department of CIP. Since 2014, he has been the federal doctor for FIPIC (Italian Wheelchair Basketball Federation) and served as Team Doctor for the Italian delegation at Sochi 2014.
Prof Sotirios Tsioumas

Prof Sotirios Tsioumas

Aesthetic Medicine Referent
Ophthalmologist Surgeon - Occuloplastics. Professor of Aesthetic Medicine - Camerino-Torino & Tor Vergata Universities of Rome, Italy. President of the Society of Aesthetic Medicine and Bloodless Surgery in Greece. Vice President of World Chinese and Complementary Medicine - Acupuncturist
Prof Teresa Abbattista

Prof Teresa Abbattista

Coordinator of the Scientific Committee
Employed as a Radiology Medical Director at ASUR Marche, Senigallia, managing responsibilities including contrast-enhanced ultrasound and breast diagnostics. Previously, from December 29, 2003, to July 25, 2004, held a similar role on a fixed-term basis, operating imaging equipment such as Siemens ICONOS R 200 and AGFA DR Thorax.

Secretarial staff

Ms Jacqueline Rudolph

Ms Jacqueline Rudolph

Administrative assistant
Mr Antonio Arcese

Mr Antonio Arcese

Administrative Office Secretary
Dr Gopi Battineni

Dr Gopi Battineni

Technical support
  • All
  • Corporate
  • costigliola
  • Directory
  • EU
  • From Members
  • Jobs
  • legal
  • NEWS
  • Non classé
  • Partners
  • PUBLICATIONS
  • save the date
  • Videos
    •   Back
    • Professor of Human Histology
    •   Back
    • Surgeon
    • Dentist
    • Reconstructive Surgery
    • Non invasive Plastic Surgery
    • Anesthesiology – Palliative care et Pain Management
    • Cardiac surgery
    • Cardiology
    • Geriatry
    • Ortho-Geriatric Medicine
    • Gynecology
    • Immunology-Serology
    • Lifestyle Medicine
    • Medical Ophthalmologist
    • Medical Pharmacology
    • Molecular diagnostics, pharmacogenetics and theragnostic.
    • New therapies
    • Obstetrics and Gynaecologist
    • Occupational medecine
    • ORL
    • Pharmacogenetics and theragnostic
    • Psychiatry
    • Public health and medical research
    • Regenerative medicine by non invasive non drug therapy
    • General medicine
    • Professors
    • Professor of Human Histology
Older PostsNewer Posts